Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-12-22
2008-09-23
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S323000, C514S326000, C514S331000, C514S254090, C546S193000, C546S194000, C546S201000, C546S233000, C546S234000, C546S213000, C546S232000, C544S360000, C544S373000, C544S379000, C544S380000, C544S400000, C544S403000
Reexamination Certificate
active
07427632
ABSTRACT:
Compounds of formula (I)in which R1, n, Z, R3and R4have any of the meanings given in the specification, are inhibitors of the serine protease Factor Xa and are useful in the treatment of thrombotic disorders.
REFERENCES:
patent: 6855715 (2005-02-01), Liebeschuetz et al.
patent: 6900196 (2005-05-01), Liebeschuetz et al.
patent: 535256 (1993-04-01), None
patent: WO 99/11657 (1999-03-01), None
patent: WO 99/11658 (1999-03-01), None
patent: WO 00/39111 (2000-07-01), None
patent: WO 00/76971 (2000-12-01), None
patent: WO 01/96303 (2001-12-01), None
Mashkovsky et al. Khimiko-Farmatsevticheskii Zhurnal,vol. 25,pp. 27-31 (1995) (English translation).
Jones, S D, et al., Bioorg. Med. Chem. Lett., vol. 11, 2001, pp. 733-736.
Liebeschuetz John Walter
Sheehan Scott Martin
Watson Brian Morgan
Bernhardt Emily
Eli Lilly and Company
Jackson Thomas E.
LandOfFree
Factor Xa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Factor Xa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Factor Xa inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3980120